Your position:
m.limatoxi.com
>>
EN
>>
EN
>>
Formulation
>>
Pfizers $11.6 Billion Double-acting Migraine Drug Generates $318 Million in First-half Revenue
>> article
Pfizers $11.6 Billion Double-acting Migraine Drug Generates $318 Million in First-half Revenue
Editor:xuezhe Clicks:
0
Date:2022-8-9 16:29:50
Keyword:
Pfizer
Healthoo Information:
Pfizers $11.6 Billion Double-acting Migraine Drug Generates $318 Million in First-half Revenue
UserLogin
UserName：
Password：
The non-formal user may read the summary, the formal user can read the whole article。
please at once register the user of Heatlhoo.com
After registration, we will provide the sample reports and the more comprehensive consulting services for you.
UserName
Contact:
Title:
Mr.
Ms.
Password
Repeat password:
Mobile
Email
Verification code:
Company Name
E-mail:xuezhe@healthoo.com
Tel.:86-10-68032463
Our services:
China Im\Ex data service
Service fees of Chinese Vision
Our service items
Online information introduction
Monthly information
Relative Information
$36.781 Billion! "Drug King" Changed! "Cosmic Factory", Pfizer is Back...
China suspends Pfizer import of Fluconazole&n...
Pfizer and Hisun signed to build a ...
Hisun and Pfizer signed agreement to est...
Abbott to build nutritional plant in Chi...
Pfizer signed MOU with Hisun for joint&n...
Market activities of healthcare giants in&nbs...
Pfizer and MSD launched new dosage form&...
Ouyi Pharma to upgrade its Azithromycin ...
Pfizer strengthens its workforce in China
Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
Tel:+86-10-68032463
map
